SXC2023 is an inhibitor for solute carrier family 7 member 11 (SLC7A11). SXC2023 exhibits antitumor efficacy, and ameliorates central nervous system disorder through downregulation of glutamate export[1].
Molecular Weight:
281.33
CAS Number:
[1695562-36-7]
Formula:
C13H15NO4S
Target:
Others
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted